Skip to menu Skip to content Skip to footer

2016

Conference Publication

Ultrasound muscle thickness for the bedside assessment of sarcopenia in patients with cirrhosis

Woodward, A. J., Wallen, M., King, S., Ward, L. C., Coombes, J. and Macdonald, G. A. (2016). Ultrasound muscle thickness for the bedside assessment of sarcopenia in patients with cirrhosis. Australian Gastroenterology Week 2016, Adelaide, Australia, 10-12 October 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13520

Ultrasound muscle thickness for the bedside assessment of sarcopenia in patients with cirrhosis

2016

Conference Publication

Safety, Adherence and Efficacy of a 4-Week Randomised-Controlled Trial of Exercise Training in Patients Awaiting Liver Transplantation

Wallen, M. P., Keating, S., Hall, A., Skinner, T., Woodward, A., Macdonald, G. and Coombes, J. (2016). Safety, Adherence and Efficacy of a 4-Week Randomised-Controlled Trial of Exercise Training in Patients Awaiting Liver Transplantation. EASL International Liver Congress, Barcelona, Spain, 13-17 April 2016. AMSTERDAM: Elsevier. doi: 10.1016/S0168-8278(16)00981-8

Safety, Adherence and Efficacy of a 4-Week Randomised-Controlled Trial of Exercise Training in Patients Awaiting Liver Transplantation

2016

Journal Article

Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician's expectation be matched by the reality?

Houghton, Christine A., Fassett, Robert G. and Coombes, Jeff S. (2016). Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician's expectation be matched by the reality?. Oxidative Medicine and Cellular Longevity, 2016 (7857186) 7857186, 1-17. doi: 10.1155/2016/7857186

Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician's expectation be matched by the reality?

2016

Journal Article

Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial)

Coombes, Jeff S., Sharman, James E. and Fassett, Robert G. (2016). Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial). The American Journal of Clinical Nutrition, 103 (1), 283-289. doi: 10.3945/ajcn.115.115477

Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial)

2016

Conference Publication

Effect Of high-intensity interval training on insulin quality in participants with metabolic syndrome

Ramos, Joyce S., Dalleck, Lance C., Borrani, Fabio, Fassett, Robert G., Keating, Shelley E., Coombes, Jeff S. and Brown, Wendy (2016). Effect Of high-intensity interval training on insulin quality in participants with metabolic syndrome. Annual Meeting of the American College of Sports Medicine (ACSM), Boston, MA, United States, May 31-Jun 04, 2016. Philadelphia, PA, United States: Lippincott Williams & Wilkins. doi: 10.1249/01.mss.0000486925.46865.d5

Effect Of high-intensity interval training on insulin quality in participants with metabolic syndrome

2016

Journal Article

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.

Zhang, Lei, Coombes, Jeff, Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, FerrarI, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M. and Johnson, David W. (2016). The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.. Redox Report, 21 (1), 14-23. doi: 10.1179/1351000215Y.0000000022

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.

2016

Conference Publication

Quality Biobanking of Chronic Kidney Disease Specimens

Gobe, G., Endre, Z., Coombes, J., Healy, H., Wilkinson, R., Tan, K., Cameron, A. and Hoy, W. (2016). Quality Biobanking of Chronic Kidney Disease Specimens. 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth Western Australia, 17–21 September 2016. Hoboken, NJ United States: Wiley-Blackwell Publishing. doi: 10.1111/nep.12888

Quality Biobanking of Chronic Kidney Disease Specimens

2016

Conference Publication

Ventilatory Threshold Predicts Episodes of Sepsis in End-Stage Liver Disease Patients Awaiting Liver Transplantation

Wallen, M. P., Hall, A., Skinner, T., Woodward, A., Coombes, J. and Macdonald, G. (2016). Ventilatory Threshold Predicts Episodes of Sepsis in End-Stage Liver Disease Patients Awaiting Liver Transplantation. EASL International Liver Congress, Barcelona, Spain, 13-17 April 2016. AMSTERDAM: Elsevier. doi: 10.1016/S0168-8278(16)00325-1

Ventilatory Threshold Predicts Episodes of Sepsis in End-Stage Liver Disease Patients Awaiting Liver Transplantation

2016

Conference Publication

The Oxygen Uptake Efficiency Slope Is Not Influenced By Beta-blockade In End-stage Liver Disease Patients

Wallen, Matthew P., Hall, Adrian, Dias, Katrin A., Ramos, Joyce S., Keating, Shelley E., Skinner, Tina L., Woodward, Aidan J., Macdonald, Graeme A., Arena, Ross and Coombes, Jeff S. (2016). The Oxygen Uptake Efficiency Slope Is Not Influenced By Beta-blockade In End-stage Liver Disease Patients. Annual Meeting of the American-College-of-Sports-Medicine (ACSM), Boston MA, United States, May 31-June 4, 2016. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1249/01.mss.0000487136.76612.ce

The Oxygen Uptake Efficiency Slope Is Not Influenced By Beta-blockade In End-stage Liver Disease Patients

2016

Conference Publication

The NHMRC Chronic Kidney Disease Centre of Research Excellence (CKD.CRE) 2015-2019: the first year

Hoy, W., Healy, H., Bonner, A., Mitchell, G., Connelly, L., Panaretto, K., Endre, Z., Coombes, J., Gobe, G., Fassett, R. and Cameron, A. (2016). The NHMRC Chronic Kidney Disease Centre of Research Excellence (CKD.CRE) 2015-2019: the first year. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17-21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12888

The NHMRC Chronic Kidney Disease Centre of Research Excellence (CKD.CRE) 2015-2019: the first year

2015

Journal Article

Assessing the effectiveness of High Intensity Interval Training (HIIT) for smoking cessation in women: HIIT to quit study protocol

Pavey, Toby G., Gartner, Coral E., Coombes, Jeff S. and Brown, Wendy J. (2015). Assessing the effectiveness of High Intensity Interval Training (HIIT) for smoking cessation in women: HIIT to quit study protocol. BMC Public Health, 15 (1309) 1309, 1-6. doi: 10.1186/s12889-015-2631-3

Assessing the effectiveness of High Intensity Interval Training (HIIT) for smoking cessation in women: HIIT to quit study protocol

2015

Journal Article

Rebuttal from Ulrik Wisløff, Jeff Coombes and Øivind Rognmo

Wisloff, Ulrik, Coombes, Jeff S. and Rognmo, Oivind (2015). Rebuttal from Ulrik Wisløff, Jeff Coombes and Øivind Rognmo. Journal of Physiology, 593 (24), 5223-5223. doi: 10.1113/JP271580

Rebuttal from Ulrik Wisløff, Jeff Coombes and Øivind Rognmo

2015

Journal Article

High intensity interval training does have a role in risk reduction or treatment of disease

Wisloff, Ulrik, Coombes, Jeff S. and Rognmo, Oivind (2015). High intensity interval training does have a role in risk reduction or treatment of disease. Journal of Physiology, 593 (24), 5215-5217. doi: 10.1113/JP271041

High intensity interval training does have a role in risk reduction or treatment of disease

2015

Journal Article

High intensity interval training favourably affects antioxidant and inflammation mRNA expression in early-stage chronic kidney disease

Tucker, Patrick S., Briskey, David R., Scanlan, Aaron T., Coombes, Jeff S. and Dalbo, Vincent J. (2015). High intensity interval training favourably affects antioxidant and inflammation mRNA expression in early-stage chronic kidney disease. Free Radical Biology and Medicine, 89, 466-472. doi: 10.1016/j.freeradbiomed.2015.07.162

High intensity interval training favourably affects antioxidant and inflammation mRNA expression in early-stage chronic kidney disease

2015

Journal Article

Biomarkers of drug-induced acute kidney injury in the adult

Gobe, Glenda C., Coombes, Jeff S., Fassett, Robert G. and Endre, Zoltan H. (2015). Biomarkers of drug-induced acute kidney injury in the adult. Expert Opinion on Drug Metabolism and Toxicology, 11 (11), 1683-1694. doi: 10.1517/17425255.2015.1083011

Biomarkers of drug-induced acute kidney injury in the adult

2015

Journal Article

Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure

Boon, Ai-Ching, Lam, Alfred K., Gopalan, Vinod, Benzie, Iris F., Briskey, David, Coombes, Jeff S., Fassett, Robert G. and Bulmer, Andrew C. (2015). Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure. Scientific Reports, 5 (15482) 15482, 1-16. doi: 10.1038/srep15482

Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure

2015

Journal Article

The role of exercise training in the management of chronic kidney disease

Howden, Erin J., Coombes, Jeff S. and Isbel, Nicole M. (2015). The role of exercise training in the management of chronic kidney disease. Current Opinion in Nephrology and Hypertension, 24 (6), 480-487. doi: 10.1097/MNH.0000000000000165

The role of exercise training in the management of chronic kidney disease

2015

Journal Article

Effects of atorvastatin on oxidative stress in chronic kidney disease

Fassett, Robert G., Robertson, Iain K., Ball, Madeleine J., Geraghty, Dominic P. and Coombes, Jeff S. (2015). Effects of atorvastatin on oxidative stress in chronic kidney disease. Nephrology, 20 (10), 697-705. doi: 10.1111/nep.12502

Effects of atorvastatin on oxidative stress in chronic kidney disease

2015

Journal Article

Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum

Boon, A. C., Hawkins, C. L., Coombes, J. S., Wagner, K. H. and Bulmer, A. C. (2015). Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum. Free Radical Biology and Medicine, 86, 259-268. doi: 10.1016/j.freeradbiomed.2015.05.031

Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum

2015

Journal Article

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

Badve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara, Carmel M. Hawley, David W. Johnson and and on behalf of the HERO Study Collaborative Group (2015). Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Canadian Journal of Kidney Health and Disease, 2 (33) 33, 1-10. doi: 10.1186/s40697-015-0066-5

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial